Skip to content
10-Q

Quarterly Report

Endo, Inc.

0002008861-24-000009

← back to feed
Filed
Aug 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 22, 2024 76.4M sh
Shares Diluted Q2 2024 · Jun 30, 2024 76.16M sh
Capex Q2 2024 · Jun 30, 2024 $8.92M
Operating Cash Flow Q2 2024 · Jun 30, 2024 $71.84M
Long Term Debt Q2 2024 · Jun 30, 2024 $2.43B
Long Term Debt Q2 2024 · Apr 23, 2024 $2.43B
Short Term Debt Q2 2024 · Jun 30, 2024 $11.25M
Short Term Debt Q2 2024 · Apr 23, 2024 $7.5M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $293.54M
Cash And Equivalents Q2 2024 · Apr 23, 2024 $220.61M
Stockholders Equity Q2 2024 · Jun 30, 2024 $1.83B
Stockholders Equity Q2 2024 · Apr 23, 2024 $1.98B
Stockholders Equity Q2 2024 · Mar 31, 2024 $0
Stockholders Equity Q2 2024 · Dec 31, 2023 $0
Current Liabilities Q2 2024 · Jun 30, 2024 $599.56M
Current Liabilities Q2 2024 · Apr 23, 2024 $518.23M
Current Assets Q2 2024 · Jun 30, 2024 $1.57B
Current Assets Q2 2024 · Apr 23, 2024 $1.71B
Total Assets Q2 2024 · Jun 30, 2024 $4.96B
Total Assets Q2 2024 · Apr 23, 2024 $5.11B
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.95
Eps Basic Q2 2024 · Jun 30, 2024 −$1.95
Sga Expense Q2 2024 · Jun 30, 2024 $95.99M
Net Income Q2 2024 · Jun 30, 2024 −$148.78M
Net Income Q2 2024 · Jun 30, 2024 −$148.78M
Net Income Q2 2024 · Mar 31, 2024 $0
Cost Of Revenue Q2 2024 · Jun 30, 2024 $333.7M
Revenue Q2 2024 · Jun 30, 2024 $284.16M